Marker Therapeutics (MRKR) Payables (2010 - 2026)
Marker Therapeutics' Payables came in at $1.02 million for Q2 2026, down 54.9% from $2.27 million a year earlier and down 46.5% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Marker Therapeutics' Payables was $1.3 million, down 25.9% from FY2024.
- Payables carries a five-year compound annual growth rate of -26.4% (FY2020 to FY2025).
- Going back by year, Payables was $1.75 million in FY2024 (+0.5%), $1.75 million in FY2023 (-30.8%), $2.52 million in FY2022 (-77.4%) and $11.13 million in FY2021 (+85.2%).
- The Q2 2026 figure represents the lowest quarterly Payables since Q4 2015.
- Year-over-year, Payables has declined for four consecutive quarters, with an average decline of 8.8% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q1 2022 (growth of 100.0%), and the weakest in Q4 2022 (a decline of 77.4%).
- Business Quant data shows MRKR's Payables at $1.91 million (Q1 2026), $1.3 million (Q4 2025) and $1.66 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | 1.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.91 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 2.27 Mn |
| Mar 31, 2025 | 2.09 Mn |
| Dec 31, 2024 | 1.75 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.95 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 2.30 Mn |
| Jun 30, 2023 | 2.66 Mn |
| Mar 31, 2023 | 4.54 Mn |
| Dec 31, 2022 | 2.52 Mn |
| Sep 30, 2022 | 5.75 Mn |
| Jun 30, 2022 | 4.74 Mn |
| Mar 31, 2022 | 7.35 Mn |
| Dec 31, 2021 | 11.13 Mn |
| Sep 30, 2021 | 7.65 Mn |
API Access
Marker Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();